These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3480961)

  • 1. [Sialoglycosphingolipid (ganglioside) specific differentiation-markers and differentiation-inducers for human myelogenous leukemia cells].
    Saito M; Nojiri H
    Rinsho Ketsueki; 1987 Aug; 28(8):1283-93. PubMed ID: 3480961
    [No Abstract]   [Full Text] [Related]  

  • 2. [Functional role of cell surface glycoconjugates in leukemic cell differentiation: a specific type of sialoglycosphingolipids (gangliosides) as potent differentiation-inducers for human myelogenous leukemia cells].
    Nojiri H; Saito M
    Rinsho Byori; 1991 Sep; Suppl 91():117-28. PubMed ID: 1758067
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
    Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
    Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bioactive sialoglycosphingolipids (gangliosides): differentiation-inducers as well as differentiation-markers in human hematopoietic cells].
    Saito M
    Hum Cell; 1989 Mar; 2(1):35-44. PubMed ID: 2519202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive gangliosides: differentiation inducers for hematopoietic cells and their mechanism(s) of actions.
    Saito M
    Adv Lipid Res; 1993; 25():303-27. PubMed ID: 8368153
    [No Abstract]   [Full Text] [Related]  

  • 6. Differentiation inducers of human myeloid leukaemia cell lines.
    Hassan HT
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):887-96. PubMed ID: 2467860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation-associated ganglioside changes in chronic myelogenous leukemia cells.
    Tsuboyama A; Sakamoto S; Takaku F
    Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1480-4. PubMed ID: 3867216
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation and characterization of gangliosides from chronic myelogenous leukemia cells.
    Westrick MA; Lee WM; Macher BA
    Cancer Res; 1983 Dec; 43(12 Pt 1):5890-4. PubMed ID: 6580065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioside GT1b induces keratinocyte differentiation without activating protein kinase C.
    Paller AS; Arnsmeier SL; Fisher GJ; Yu QC
    Exp Cell Res; 1995 Mar; 217(1):118-24. PubMed ID: 7867710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory control of the proliferation ad differentiation of normal and leukemia cells.
    Metcalf D
    Natl Cancer Inst Monogr; 1982; 60():123-31. PubMed ID: 6981771
    [No Abstract]   [Full Text] [Related]  

  • 11. Appearance of a novel type of ganglioside (GD1 alpha) in a differentiation-resistant clone of mouse myeloid leukemia cells, M1-R1.
    Taki T; Maeda H; Arai K; Matsumoto M; Kon K; Ando S
    Cell Struct Funct; 1988 Feb; 13(1):61-72. PubMed ID: 3163528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of differentiation of cultured mouse monocytic leukemia cells (Mm-A) by inducers different from those of parent myeloblastic leukemia cells (M1).
    Kasukabe T; Honma Y; Hozumi M
    Jpn J Cancer Res; 1985 Nov; 76(11):1056-63. PubMed ID: 3936826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro response to erythropoietin in erythroblastic transformation of chronic myelogenous leukemia.
    Greenberg BR; Hirasuna JD; Woo L
    Exp Hematol; 1980 Jan; 8(1):52-6. PubMed ID: 6931816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of normal differentiation and restoration of the normal phenotype in leukemia.
    Sachs L
    Natl Cancer Inst Monogr; 1982; 60():221-7. PubMed ID: 6981773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic myelogenous leukemia. Acute transformation].
    Uzuka Y
    Rinsho Ketsueki; 1984 Mar; 25(3):288-98. PubMed ID: 6590887
    [No Abstract]   [Full Text] [Related]  

  • 16. T cells and probably B cells arise from the malignant clone in chronic myelogenous leukemia.
    Fauser AA; Kanz L; Bross KJ; Löhr GW
    J Clin Invest; 1985 Mar; 75(3):1080-2. PubMed ID: 3920244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity in normal and leukemic hemopoiesis.
    McCulloch EA
    Prog Clin Biol Res; 1984; 148():59-70. PubMed ID: 6379674
    [No Abstract]   [Full Text] [Related]  

  • 18. Membrane protein hMYADM preferentially expressed in myeloid cells is up-regulated during differentiation of stem cells and myeloid leukemia cells.
    Wang Q; Li N; Wang X; Shen J; Hong X; Yu H; Zhang Y; Wan T; Zhang L; Wang J; Cao X
    Life Sci; 2007 Jan; 80(5):420-9. PubMed ID: 17097684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [2 cases of chronic myelogenous leukemia with megakaryocytic transformation].
    Ino T; Saito M; Shigemura H; Morishita Y; Hirano M; Shamoto M
    Rinsho Ketsueki; 1982 Apr; 23(4):484-92. PubMed ID: 6957630
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of a differentiation-inhibitory activity from nondifferentiating mouse myeloid leukemia cells.
    Okabe-Kado J; Hayashi M; Honma Y; Hozumi M
    Cancer Res; 1985 Oct; 45(10):4848-52. PubMed ID: 3861237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.